Azenta, Inc. (AZTA): insider & executive buying
Azenta, Inc. · Health Care · ref. ETF XLV · price $33.61
In short — 1 insider bought Azenta, Inc. over ~6 months (1 buy, total $164k, latest May 18, 26). Public Form 4 data, informative (not a performance signal).
Are Azenta, Inc.'s executives buying their own shares? Here are the disclosed insider buys over the last 6 months — a transparency data point, not an outperformance signal.
📈 1-year price
$33.61+12.3% over range
Aug 28, 25low $16.02 · high $41.01Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 2 analysts
Latest insider buys on Azenta, Inc.
| Date | Insider | Role | Shares | Amount |
|---|---|---|---|---|
| May 18, 26 | Cornog William L | Dir | 10,000 | $164k |
⚠️ Open-market buys reported to the SEC (Form 4). Transparency data, not advice nor an outperformance signal (our backtests show no reliable edge).
Frequently asked questions
Have Azenta, Inc.'s executives bought shares recently?
1 Azenta, Inc. insider(s) bought $164k over ~6 months (latest May 18, 26). A buy shows confidence, but our backtests show no performance edge.
Is insider buying a good signal for AZTA?
It's useful transparency data, but NOT a performance guarantee: our historical tests show no reliable edge from following insider buys. Cross-check with fundamentals and analyst views.
Where does this data come from?
From Form 4 filings with the SEC (mandatory for officers and 10%+ holders), aggregated and refreshed regularly.
💬 A question about Azenta, Inc.? The JPI assistant answers using our backtest data.
Keep exploring Azenta, Inc.